Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 250,218 | 226,200 | 213,670 | 235,848 | 249,539 |
| Cost of Goods | 59,436 | 49,408 | 48,815 | 50,184 | 52,445 |
| Gross Profit | 190,782 | 176,792 | 164,855 | 185,664 | 197,094 |
| Operating Expenses | 177,344 | 173,381 | 164,446 | 169,130 | 181,868 |
| Operating Income | 13,874 | 3,819 | 1,224 | 16,718 | 15,671 |
| Interest Expense | 240 | 123 | 49 | 259 | 411 |
| Other Income | 1,831 | 481 | 619 | 2,358 | 1,479 |
| Pre-tax Income | 15,465 | 4,177 | 1,794 | 18,817 | 16,739 |
| Income Tax | 8,506 | 5,772 | 8,456 | 8,373 | 7,449 |
| Net Income Continuous | 6,959 | -1,595 | -6,662 | 10,444 | 9,290 |
| Minority Interests | -556 | 180 | -140 | 789 | -112 |
| Net Income | $7,515 | $-1,775 | $-6,522 | $9,655 | $9,402 |
| EPS Basic Total Ops | 0.41 | -0.07 | -0.36 | 0.52 | 0.49 |
| EPS Basic Continuous Ops | 0.38 | -0.07 | -0.36 | 0.56 | 0.49 |
| EPS Diluted Total Ops | 0.41 | -0.07 | -0.36 | 0.52 | 0.49 |
| EPS Diluted Continuous Ops | 0.38 | -0.07 | -0.36 | 0.56 | 0.49 |
| EPS Diluted Before Non-Recurring Items | 0.61 | 0.60 | -0.15 | 0.74 | 0.73 |
| EBITDA(a) | $23,663 | $14,105 | $10,791 | $26,322 | $25,916 |